المرضى الدوليونالأخباراتصل بنا
مستشفيات جامعةحاجت تبه
موعد
AR
  1. Home
  2. الأطباء
  3. أ.م.د. Neşe Ünver
أ.م.د. Neşe Ünver

أ.م.د.

Neşe Ünver

Basic Oncology · مستشفى الأورام

احجز موعدًا0312 305 44 08

This page is not yet available in العربية. The Turkish version is shown below.

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (29) ↗

Articles 21

  1. Characterization of Carcinogenesis Resistance in Anatolian Blind Mole-rat Mesenchymal Stem Cells and Assessment of Transcriptomic Signatures.Unver N., Tavukcuoglu E., Budak B., Sezginer O., Ozturk S. C., Ozturk S. E., et al.Stem cells (Dayton, Ohio), 2026 (SCI-Expanded, Scopus)
  2. The impact of aspirin on PD-L1 expression and alteration of M2 polarization in non-small cell lung cancerUnver N., Uluturk S., Tavukcuoglu E., Duymaz Yilmaz E., Kaymaz Y., Esendagli G.Inflammation Research, cilt.74, sa.1, 2025 (SCI-Expanded, Scopus)
  3. Aspirin's effect on macrophages beyond its chemopreventive role in inflammation and cancer.Unver N.Inflammopharmacology, cilt.33, ss.5735-5743, 2025 (SCI-Expanded, Scopus)
  4. Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization.Sezginer O., Unver N.Inflammation research : official journal of the European Histamine Research Society ... [et al.], cilt.73, ss.1411-1423, 2024 (SCI-Expanded, Scopus)
  5. Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull’s eye for solid cancer immunotherapy approachesUnver N.Clinical and Experimental Medicine, cilt.23, sa.7, ss.3171-3177, 2023 (SCI-Expanded, Scopus)
  6. Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppressionUnver N., Tavukcuoglu E., Esendagli G.Life Sciences, cilt.311, 2022 (SCI-Expanded, Scopus)
  7. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.Tanaka I., Dayde D., Tai M. C., Mori H., Solis L. M., Tripathi S. C., et al.Journal of the National Cancer Institute, cilt.114, ss.290-301, 2022 (SCI-Expanded, Scopus)
  8. In-Silico Analysis of The Correlation Between PD-L1 and Pro-Inflammatory Type Interleukins and The Distribution of Their Potential Primary Sources in KRAS-Mutated Non-Small Cell Lung CarcinomaÜnver N.Acta Medica, cilt.52, sa.3, ss.189-196, 2021 (TRDizin)
  9. Revisiting CCL-type chemokines in breast cancer and its milieu: Prominent targetable chemokines, CCL8 and CCL21.Unver N.Bioscience reports, cilt.41, 2021 (SCI-Expanded, Scopus)
  10. Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools.Unver N.Medical oncology (Northwood, London, England), cilt.38, ss.68, 2021 (SCI-Expanded, Scopus)
  11. Cancer stemness as a target for immunotherapy is shaped by pro-inflammatory stress.Unver N.Current stem cell research & therapy, cilt.16, ss.792-800, 2021 (SCI-Expanded, Scopus)
  12. Transcriptional splice variants of CD40 and its prognostic value in breast cancer.Ünver N., Yöyen E., Weber B., Esendağli G.Turkish journal of biology = Turk biyoloji dergisi, cilt.44, ss.73-81, 2020 (SCI-Expanded, Scopus, TRDizin)
  13. Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target.Unver N.Cytokine & growth factor reviews, 2019 (SCI-Expanded, Scopus)
  14. IL22 Promotes <i>Kras</i>-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties.KHOSRAVI N., CAETANO M., CUMPIAN A., Unver N., DE L. G. R. C., NOBLE O., et al.Cancer immunology research, cilt.6, ss.788-797, 2018 (SCI-Expanded, Scopus)
  15. IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.Unver N., MCALLISTER F.Cytokine & growth factor reviews, cilt.41, ss.10-17, 2018 (SCI-Expanded, Scopus)
  16. Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.Unver N., Delgado O., Zeleke K., Cumpian A., Tang X., Caetano M., et al.International journal of cancer, cilt.142, ss.1405-1417, 2018 (SCI-Expanded, Scopus)
  17. Akciğer Tümörigenezinde ve Kanserle İlişkili İnflamasyonda Chemerin'in Düzenleyici Rolü.Ünver N., Esendağlı G., Canpınar H., Güç D., Esendağlı G.Acta Medica, cilt.49, sa.1, ss.16-25, 2018 (TRDizin)
  18. Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients.HALACLI B., Unver N., HALACLI S., CANPINAR H., ERSOY E., OCAL S., et al.Journal of critical care, cilt.35, ss.185-90, 2016 (SCI-Expanded, Scopus)
  19. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.CAETANO M., ZHANG H., CUMPIAN A., GONG L., Unver N., OSTRIN E., et al.Cancer research, cilt.76, ss.3189-99, 2016 (SCI-Expanded, Scopus)
  20. CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors.Unver N., ESENDAGLI G., YILMAZ G., GUC D.Cytokine, cilt.75, ss.330-7, 2015 (SCI-Expanded, Scopus)
  21. Molecular analysis of Chanarin-Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 geneEMRE S., Unver N., EVANS S., YÜZBAŞIOĞLU A., GÜRAKAN F., GÜMRÜK F., et al.EUROPEAN JOURNAL OF MEDICAL GENETICS, cilt.53, sa.3, ss.141-144, 2010 (SCI-Expanded, Scopus)

Conference papers 6

  1. Desmin ve LaminB: Farklı Konumlanan İki Proteinin Bağlanma Partnerlerinin Proteomik AnaliziKural Mangıt E., Ünver N., Dinçer P. R.
  2. Myo-inositol modulates the tumor microenvironment in a mouse model of lung cancer chemopreventionUnver N., Zeleke K. T., Tang X., Holt S., Moghaddam S. J. M., Wang H., et al.
  3. The effects of Cancer Associated Fibroblasts on mechanisms of immune evasion in a rat chemical mammary carcinoma modelGÜNAYDIN G., DÖLEN Y., ÜNVER N., KESİKLİ S. A., GÜÇ D.
  4. Kanserle İlişkili Fibroblastların Tümörün İmmün Kaçış Mekanizmalarındaki Fonksiyonel Rollerinin Sıçan Kimyasal Meme Kanseri Modelinde AraştırılmasıGÜNAYDIN G., DÖLEN Y., ÜNVER N., KESİKLİ S. A., GÜÇ D.
  5. SIÇAN KİMYASAL MEME KANSERİ MODELİNDE KANSERLE İLİŞKİLİ FİBROBLASTLARIN TANIMLANMASI VE BU HÜCRELERİN TÜMÖRÜN İMMÜN KAÇIŞ MEKANİZMALARINDAKİ FONKSİYONEL ROLLERİNİN ARAŞTIRILMASIGÜNAYDIN G., DÖLEN Y., ÜNVER N., KESİKLİ S. A., GÜÇ D.
  6. Functional analysis of neutrophils cultured in supernatant of CXCL7 overexpressing lung cancer cellsÜNVER N., ESENDAĞLI G., Guc D.

Kitaplar 2

  1. Mechanisms of Antitumor Immunity and ImmunosurveillanceMohindroo C., Ünver N.
  2. Targets and Strategies for Cancer ImmunopreventionÜnver N., Mohindroo C.

اتصل بنا

Phone
0312 305 44 08
Department
Basic Oncology, مستشفى الأورام

آخر تحديث: